IRZ-01

N/A

Report date: 2025/04/17 16:56:50

Base Information

Drug NameIRZ-01
Drug Alias NameIRZ-01
ClassificationVaccines
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIrazu Oncology LLC
China Registration ClassN/A

Develop Information

Active CompaniesIrazu Oncology LLC
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A